TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07680439: Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

Sponsor: BrainChild Bio, Inc · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 75 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$1,339,800

Rescue Site Savings

+$877,800

Unlock Full NCT07680439 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07680439 Rescue Dossier →